Keeley Teton Advisors, LLC Bausch Health Companies Inc. Transaction History

Keeley Teton Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$7.06 - $23.63 $169,214 - $566,363	-23,968 Reduced 30.19%	55,434 $463,000
Q1 2022 May 18, 2022	BUY	$21.6 - $27.79 $107,978 - $138,922	4,999 Added 6.72%	79,402 $1.81 Million
Q4 2021 Feb 11, 2022	BUY	$23.0 - $29.01 $213,946 - $269,851	9,302 Added 14.29%	74,403 $2.05 Million
Q3 2021 Nov 12, 2021	BUY	$25.04 - $30.06 $988,804 - $1.19 Million	39,489 Added 154.18%	65,101 $1.81 Million
Q2 2021 Aug 13, 2021	BUY	$27.43 - $32.7 $702,537 - $837,512	25,612 New	25,612 $751,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Keeley Teton Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Keeley Teton Advisors, LLC with notifications on news.